Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques - sprookjes - yvandenbroek - TriplyDB

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques

http://www.wikidata.org/entity/Q58699804

about

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques

http://www.wikidata.org/entity/Q58699804

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Mucosal antibody responses to ...... Mauritian cynomolgus macaques

@en

Mucosal antibody responses to ...... Mauritian cynomolgus macaques

@nl

type

label

Mucosal antibody responses to ...... Mauritian cynomolgus macaques

@en

Mucosal antibody responses to ...... Mauritian cynomolgus macaques

@nl

prefLabel

Mucosal antibody responses to ...... Mauritian cynomolgus macaques

@en

Mucosal antibody responses to ...... Mauritian cynomolgus macaques

@nl

P1433

Q58699804-EB110E71-C1D5-4D9F-AEEB-5639218D7D4B

P1476

Q58699804-25C7C346-8A2E-4259-A280-971C09D9F113

P2093

Q58699804-075223B5-5079-44FD-8CE0-E079BE172CE0

Q58699804-0BF78426-531E-4BEB-844B-BA57B16F6AE7

Q58699804-15FB0DE9-F828-406F-B193-23F5E410CB2E

Q58699804-276206D6-84CA-4797-AB92-C700C075C08E

Q58699804-2B9FCCF1-A385-40AF-8167-BD63A38220A8

Q58699804-2F55A2B7-9DB6-4E98-A6E3-33EFCD7A88A2

Q58699804-54E8D381-928C-4069-8F93-E674B7064F6E

Q58699804-58CB8A1A-EDFE-4B03-A926-40029A5BEA08

Q58699804-6BDABFB9-AF71-4E9E-B4D0-93F6FA979338

Q58699804-7A8A7F34-3EEE-445D-835B-34334E3C9952

P2860

Q58699804-057F4A84-A137-4554-A8EB-4AF0FCBAABD2

Q58699804-059EDD0C-8F3A-4799-BB62-720343060B96

Q58699804-06602AF8-3D30-44AE-BA79-50A5EE19E588

Q58699804-06625747-855B-420F-9D04-6F1E9C30EB64

Q58699804-09C24D69-3DF8-44F8-A103-A99BD20EA5FC

Q58699804-0ACEBC7C-AB27-4CF4-9389-1AC3AC26603F

Q58699804-0BECB66A-49AB-40EE-ADFD-CCE3461765BF

Q58699804-193A5C32-6808-4FC6-BE2B-DF7AEB4B7501

Q58699804-1F2706FB-D11D-48EF-9B6B-07903F67CE3F

Q58699804-25E2171E-59CE-4977-844D-5ED6E67344A6

P304

Q58699804-04FCCDB5-72F1-427F-B008-E76B375FAD24

P31

Q58699804-E6D3788F-0801-40DD-A3D7-47F0849BB280

P356

Q58699804-82F22872-C898-46BA-8707-7B5499257F3D

P407

Q58699804-114DD6E2-B7BE-4DD0-962E-C35630BFB97C

P433

Q58699804-89FDC8BF-8835-4AC9-B3F3-3F7ED0640BE2

P478

Q58699804-49F56A73-9183-4C94-812A-FD0D1B803AC4

P50

Q58699804-169D018B-CEE7-4208-93B9-CF03021F0E63

Q58699804-383039A6-FB6F-4FE4-907D-F965A496F6D4

Q58699804-C32E0408-A898-41F4-BD7C-198C68D1921A

Q58699804-EC34EEFD-907E-4123-AA17-85CF9558F6FC

P577

Q58699804-60F66E4E-2E07-4D3F-B411-11FD6726B82B

P698

Q58699804-D22DD04A-8AB9-49FE-8B6B-3F69DFB40A5B

P932

Q58699804-43F4C683-1AE4-4325-999B-137E6DBBA17F

P356

JOURNAL.PONE.0202997

P1433

P1476

Mucosal antibody responses to ...... Mauritian cynomolgus macaques

@en

P2093

Binhua Liang

http://www.w3.org/2001/XMLSchema#string

Dane Schalk

http://www.w3.org/2001/XMLSchema#string

Eva Rakasz

http://www.w3.org/2001/XMLSchema#string

Francis A Plummer

http://www.w3.org/2001/XMLSchema#string

Hongzhao Li

http://www.w3.org/2001/XMLSchema#string

James B Whitney

http://www.w3.org/2001/XMLSchema#string

Lewis R Liu

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

Maria J Alonso

http://www.w3.org/2001/XMLSchema#string

Mohammad Abul Kashem

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Virus maturation as a new HIV-1 therapeutic target

Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.

Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract

Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers

Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract

Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

P304

e0202997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0202997

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

José Crecente-Campo

Nancy Schultz-Darken

P577

2018-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30153293

http://www.w3.org/2001/XMLSchema#string

P932

6112674

http://www.w3.org/2001/XMLSchema#string